Michael McGowan SHL Group

Michael McGowan is Director of Market Intelligence with SHL Group, one of the world’s leading solution providers of advanced drug delivery systems. He has 30 years’ experience in the medical technology and biomedical research industries. Michael started his career with Becton Dickinson (BD), gaining significant sales, marketing and industry experience with prefilled syringes, pen injectors and pen needles. He joined SHL Group in 2016 and is responsible for delivering market insights that impact the design, development and commercialisation of SHL’s drug delivery devices. Michael splits his time between SHL Group’s office in Stockholm and his home office in Grenoble, France.